Detalles de la búsqueda
1.
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
N Engl J Med
; 383(14): 1328-1339, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997907
2.
Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Blood
; 133(2): 137-146, 2019 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341058
3.
Atezolizumab for PD-L1-Selected Patients with NSCLC. Reply.
N Engl J Med
; 384(6): 584-585, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567202
4.
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer.
Cancer Sci
; 109(5): 1592-1601, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500843
5.
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.
Gastric Cancer
; 21(3): 429-438, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29058097
6.
Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study.
Jpn J Clin Oncol
; 48(8): 736-742, 2018 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060000
7.
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study.
Gastric Cancer
; 20(2): 332-340, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26956689
8.
Incorporating Unstructured Patient Narratives and Health Insurance Claims Data in Pharmacovigilance: Natural Language Processing Analysis of Patient-Generated Texts About Systemic Lupus Erythematosus.
JMIR Public Health Surveill
; 7(6): e29238, 2021 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255719
9.
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC.
J Thorac Oncol
; 16(11): 1872-1882, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34265434
10.
Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.
Lung Cancer
; 121: 37-40, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29858024
11.
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.
Int J Hematol
; 108(5): 499-509, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30027429
12.
Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance.
JMIR Public Health Surveill
; 3(1): e10, 2017 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28235749
13.
Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP.
J Clin Oncol
; 35(14): 1515-1521, 2017 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28296581
14.
Bias in spontaneous reporting of adverse drug reactions in Japan.
PLoS One
; 10(5): e0126413, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25933226
15.
Interpretation of HER2 tests in gastric cancer: confirmation of interobserver differences and validation of a QA/QC educational program.
Virchows Arch
; 464(5): 539-45, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24633707
16.
Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40].
Lung Cancer
; 132: 160, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31029398
Resultados
1 -
16
de 16
1
Próxima >
>>